![Timothy Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Lynch
Plus aucun poste en cours
Fortune : 25 M $ au 31/05/2026
Profil
Mr. Timothy P.
Lynch was previously employed as an Independent Director by InSite Vision, Inc., a Managing Member by Stonepine Capital Management LLC, an Independent Director by Nabi Biopharmaceuticals, an Independent Director by Allos Therapeutics, Inc., a President & Chief Executive Officer by Neurostat Pharmaceuticals, Inc., a President & Chief Executive Officer by Vivo Therapeutics, Inc., a Chief Financial Officer by Tercica, Inc., a Chief Financial Officer by InterMune, Inc., a Principal by Goldman Sachs & Co. LLC, and an Advisor by Healthcare Royalty Management LLC.
He also served on the board at Aradigm Corp., BioForm Medical, Inc., ClearFlow, Inc. and Elan Corp.
Plc.
He received his undergraduate degree from Colgate University and an MBA from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Evolus, Inc.
 Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins 5,93 % | 17/04/2026 | 3 835 363 ( 5,93 % ) | 25 M $ | 31/05/2026 |
Anciens postes connus de Timothy Lynch
| Sociétés | Poste | Fin |
|---|---|---|
Stonepine Capital Management LLC
 Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Director of Investments | 01/09/2024 |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Directeur/Membre du Conseil | 31/12/2011 |
| INSITE VISION INC. | Directeur/Membre du Conseil | 16/09/2011 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Directeur/Membre du Conseil | 04/06/2009 |
BioForm Medical, Inc.
 BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Directeur/Membre du Conseil | 19/02/2010 |
Formation de Timothy Lynch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
BioForm Medical, Inc.
BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Health Technology |
ClearFlow, Inc.
 ClearFlow, Inc. Medical SpecialtiesHealth Technology Develops surgical and medical devices | Health Technology |
Stonepine Capital Management LLC
Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Neurostat Pharmaceuticals, Inc. | |
Vivo Therapeutics, Inc. |
Choisissez Zonebourse 
